Pure Global

Cefudine-HIV 1/2 - Taiwan Registration 59ddb5d8b805e0a289a32bc3fe72737d

Access comprehensive regulatory information for Cefudine-HIV 1/2 in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 59ddb5d8b805e0a289a32bc3fe72737d and manufactured by FUJIREBIO INC., HACHIOJI FACILITY. The authorized representative in Taiwan is Grand Marquis IVD CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
59ddb5d8b805e0a289a32bc3fe72737d
Registration Details
Taiwan FDA Registration: 59ddb5d8b805e0a289a32bc3fe72737d
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Cefudine-HIV 1/2
TW: ่ณฝๅฏŒๅฎš-HIV 1/2
Risk Class 3

Registration Details

59ddb5d8b805e0a289a32bc3fe72737d

DHA00601316704

Company Information

Product Details

Particle agglutination test for anti-HIV 1/2 in human serum or plasma for screening.

B Hematology, pathology, and genetics

import

Dates and Status

Oct 11, 2005

Nov 23, 2025